Effects of cyclosporin A and FK-506 on stem cell factor–induced histamine secretion and growth of human mast cells

Abstract

Stem cell factor (SCF) is a key regulator of human mast cells (MCs) and a potential mediator of allergy. In this study the effects of cyclosporin A (CSA) and FK-506, two potent immunosuppressive drugs, on SCF-dependent histamine release and growth of human MCs were analyzed. Preincubation of tissue MCs with CSA (3 μg/ml) resulted in inhibition of histamine release provoked by either recombinant human (rh) SCF (70.3% ± 20.6% inhibition, p < 0.001) or anti-IgE (76.7% ± 21.9%, p < 0.001) or by rhSCF+ anti-IgE (77.4% ± 13.9%, p < 0.001). Almost the same inhibition was produced by FK-506 (rhSCF: 82.0% ± 18.9% inhibition, p < 0.001; anti-IgE: 71.5% ± 16.7%, p < 0.001; rhSCF+ anti-IgE: 70.0% ± 7.3%, p < 0.001). The effects of CSA and FK-506 on SCF-dependent release of histamine were dose-dependent (IC 50: CSA, 1 to 10 ng/ml; FK-506, 0.3 to 3 ng/ml). IC 50 values about three to 10 times higher were found for MCs preincubated with rhSCF before anti-IgE activation, compared with anti-IgE or SCF alone. SCF-dependent differentiation of human MCs was analyzed in a long-term suspension culture system ( n = 6). Unexpectedly, CSA and FK-506 were unable to suppress, but even enhanced SCF-dependent growth of MCs and formation of MC tryptase in long-term culture. Together, CSA and FK-506 inhibit SCF-dependent release of histamine from human MCs and even augment SCF-dependent growth of human MCs in long-term culture. (J A LLERGY C LIN I MMUNOL 1996;98:389-99.)